Jim Cramer's 'Mad Money' Recap: Time to Make Room for Alibaba
at The Street - Mon Sep 15, 7:00PM CDT
The market is getting weird and the fast-growing, high-multiple stocks are getting clobbered, Cramer says.
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - 35 mins ago
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
Final Glance: Biotechnology companies
AP - Mon Sep 15, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
Look for Shares of Celgene to Potentially Rebound after Yesterday's 2.25% Sell Off
Comtex SmarTrend(R) - Mon Sep 15, 3:51PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $88.22 to a high of $91.05. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $90.72 on volume of 4.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Nasdaq Falls Hard, But Apple Resilient On iPhone Orders
at Investor's Business Daily - Mon Sep 15, 1:55PM CDT
The Dow Jones industrial average and S&P 500 traded in a tight range Monday, but the Nasdaq took a beating as profit-taking hit several recent highfliers. The Nasdaq moved off lows but still fell 0.9%, hurt by weakness in Tesla Motors (TSLA). Shares...
Midday Glance: Biotechnology companies
AP - Mon Sep 15, 12:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
Jim Cramer Answers Twitter (TWTR) Questions on Alibaba IPO, Yahoo! (YHOO), Apple (AAPL) and More
at The Street - Mon Sep 15, 11:47AM CDT
TheStreet's Jim Cramer answers Twitter (TWTR) questions from the floor of the New York Stock Exchange, and he first tackles the upcoming Alibaba IPO.
Nasdaq Underperforms As Leading Growth Stocks Take Heat
at Investor's Business Daily - Mon Sep 15, 10:49AM CDT
The Dow Jones industrial average and S&P 500 held up well Monday, but the Nasdaq took a hit ahead of Tuesday's start of a two-day Federal Reserve meeting. The Nasdaq slumped 1.1%, weighed down by software and solar names. The Dow edged higher, helped...
Early Glance: Biotechnology companies
AP - Mon Sep 15, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
Stocks Stumble At Open; Mobileye Rebounds
at Investor's Business Daily - Mon Sep 15, 9:26AM CDT
Stocks stumbled in Monday's early going amid some mixed economic reports. The Nasdaq slumped 0.8% to its lowest level since Aug. 22. Biotech, solar and software were among the day's worst groups. The S&P 500 slipped 0.2% and the Dow Jones industrial...
These 7 States Have the Highest Rates of Pancreatic Cancer
Sean Williams, The Motley Fool - Motley Fool - Sat Sep 13, 11:17AM CDT
Source: National Cancer Institute via Wikimedia Commons . The word "cancer" is scary regardless of the type, but few types of cancer are as lethal as pancreatic cancer. Based on estimates from the American Cancer Society in 2013, an estimated...
Celgene Falls 2.26% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Sep 11, 3:38PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $90.90 to a high of $93.95. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $92.52 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of Celgene After 2.26% Loss
Comtex SmarTrend(R) - Thu Sep 11, 3:38PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $90.90 to a high of $93.95. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $92.52 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Stocks Bounce As Nasdaq, S&P 500 Close With Small Gains
at Investor's Business Daily - Thu Sep 11, 3:17PM CDT
The stock market fought back from session lows, closing mostly higher Thursday. The Nasdaq had been down as much as 0.6% in morning trading, but found support around 4560 twice during the session. It closed with a 0.1% gain. The S&P 500 also added...
Stocks Show Modest Losses; Biotechs Pressured Again
at Investor's Business Daily - Thu Sep 11, 1:46PM CDT
Major averages showed modest losses with a little over one hour remaining in Thursday's session. The Nasdaq lost 0.2%, hurt somewhat by a fresh round of selling in biotechland. The Dow Jones industrial average and S&P 500 gave up 0.2% and 0.1%,...